Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
DIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-Flu 2025-01-09 03:48
Latest Updates of Viva Biotech's Portfolio Companies 2025-01-08 20:19
111, Inc. Announces ADS Ratio Change 2025-01-08 18:00
Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report 2025-01-08 16:12
GenScript Biotech Becomes a PSCI Supplier Partner, Advancing a Sustainable Pharmaceutical Supply Chain 2025-01-08 11:30
Insilico Received Positive Topline Results from Two Phase 1 Trials of ISM5411, New Drug Designed Using Generative AI for the Treatment of Inflammatory Bowel Disease 2025-01-07 22:00
Alebund Pharmaceutical announced the 1st closing of RMB 550 million in Series C financing 2025-01-07 21:00
Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment 2025-01-07 20:14
U.S. FDA Granted Priority Review to Dizal's Sunvozertinib New Drug Application 2025-01-07 18:00
Akeso to Share Global Strategy for New Drug Development at the 43rd J.P. Morgan Healthcare Conference 2025-01-07 11:18
The Registrational Clinical Data of Glecirasib was Published in Nature Medicine 2025-01-07 08:30
Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma 2025-01-07 08:00
Technoderma Medicines Completes Positive Ph2a Proof- of Concept Trial with Topical TDM-180935 Ointment for Atopic Dermatitis 2025-01-06 21:00
I-Mab Announces Portfolio Prioritization of Givastomig (CLDN18.2 x 4-1BB Bispecific Antibody) as Lead Clinical Program 2025-01-06 20:00
Asieris and CDC Sign Investigational Product Supply Agreement for APL-1202 in Free-Living Amoeba Infections Treatment under Expanded Access Investigational New Drug Program 2025-01-06 18:05
Innovent to Participate and Present at the 43rd Annual J.P. Morgan Healthcare Conference 2025-01-06 08:00
Chime Biologics and Mabgeek Achieve MG-K10 PPQ Milestone, Advancing Atopic Dermatitis and Asthma Therapies Antibody Drug MG-K10 Late-Stage Clinical Trials and Commercialization 2025-01-03 21:15
GRIT Bio Appoints Jie Jia, Ph.D., as Chief Operating Officer 2025-01-03 15:30
Nona Biosciences Announces Update on Its Collaborator DualityBio's Antibody-Drug Conjugate (ADC) Collaboration with BeiGene 2025-01-03 13:30
Innovent Announces Second New Drug Application of DOVBLERON ® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China's National Medical Products Administration 2025-01-03 08:00
1 2 3 4 5 420